Cardinal Health, Inc. $CAH Shares Purchased by Swiss National Bank

Swiss National Bank lifted its position in Cardinal Health, Inc. (NYSE:CAH) by 7.2% in the first quarter, HoldingsChannel reports. The firm owned 697,300 shares of the company’s stock after buying an additional 46,900 shares during the period. Swiss National Bank’s holdings in Cardinal Health were worth $147,346,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Norges Bank acquired a new position in Cardinal Health in the 4th quarter valued at about $790,344,000. Wellington Management Group LLP increased its holdings in shares of Cardinal Health by 153.2% during the 3rd quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock worth $911,010,000 after buying an additional 3,511,579 shares during the last quarter. Marshall Wace LLP increased its holdings in shares of Cardinal Health by 1,328.1% during the 4th quarter. Marshall Wace LLP now owns 951,259 shares of the company’s stock worth $195,484,000 after buying an additional 884,648 shares during the last quarter. Bessemer Group Inc. raised its position in shares of Cardinal Health by 7,053.4% during the 1st quarter. Bessemer Group Inc. now owns 750,038 shares of the company’s stock valued at $158,491,000 after buying an additional 739,553 shares during the period. Finally, SG Americas Securities LLC raised its position in shares of Cardinal Health by 3,829.1% during the 4th quarter. SG Americas Securities LLC now owns 727,511 shares of the company’s stock valued at $149,504,000 after buying an additional 708,995 shares during the period. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research analysts recently weighed in on CAH shares. Morgan Stanley increased their price objective on Cardinal Health from $245.00 to $255.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 28th. Evercore reduced their target price on Cardinal Health from $260.00 to $240.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 8th. Bank of America upped their price target on Cardinal Health from $240.00 to $260.00 and gave the company a “buy” rating in a research note on Thursday, July 2nd. William Blair started coverage on Cardinal Health in a report on Tuesday, April 28th. They set an “outperform” rating for the company. Finally, Citigroup reissued a “buy” rating on shares of Cardinal Health in a research report on Thursday, July 2nd. Fifteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, Cardinal Health currently has a consensus rating of “Moderate Buy” and a consensus price target of $249.13.

Cardinal Health Stock Performance

NYSE CAH opened at $228.57 on Monday. The firm has a market cap of $53.53 billion, a price-to-earnings ratio of 34.95, a PEG ratio of 1.12 and a beta of 0.49. The firm has a 50 day simple moving average of $216.25 and a 200-day simple moving average of $213.81. Cardinal Health, Inc. has a one year low of $137.75 and a one year high of $243.21.

Cardinal Health (NYSE:CAH) last announced its earnings results on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, topping the consensus estimate of $2.79 by $0.38. The firm had revenue of $60.94 billion for the quarter, compared to the consensus estimate of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The firm’s revenue for the quarter was up 11.0% on a year-over-year basis. During the same period in the prior year, the firm earned $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Equities analysts predict that Cardinal Health, Inc. will post 10.77 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st were given a dividend of $0.5158 per share. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.06 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend was Wednesday, July 1st. Cardinal Health’s dividend payout ratio is currently 31.50%.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.